These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6779765)

  • 1. [Myocardial protection during ischemic cardiac arrest. Hemodynamic study of the effects of allopurinol in a cardioplegic solution].
    Périer P; Fabiani JN; Bocher M; Massoud H; Carpentier A; Dubost C
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):713-8. PubMed ID: 6779765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ionic bases of cardioplegic solutions. II. Influence of the ionic composition of a cardioplegic solution on the metabolic and functional preservation of ischemic myocardium. Experimental evaluation with phosphorus 31 nuclear magnetic resonance and applications to cardiac surgery].
    Menasche P; Groussett C; Piwnica A
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1465-74. PubMed ID: 6322715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
    Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
    Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.
    Liu X; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
    Circulation; 1994 Nov; 90(5 Pt 2):II316-20. PubMed ID: 7955273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lower systemic temperature enhance cardioplegic myocardial protection?
    Grover FL; Fewel JG; Ghidoni JJ; Trinkle JK
    J Thorac Cardiovasc Surg; 1981 Jan; 81(1):11-20. PubMed ID: 7453211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog.
    Rosenfeldt FL; Hearse DJ; Canković-Darracott S; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):29-38. PubMed ID: 7350386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of the acutely injured heart--deleterious effects of hypothermia.
    Ting W; Spotnitz AJ; Mackenzie JW; Chen WH; Conway RS
    J Surg Res; 1994 Jan; 56(1):108-11. PubMed ID: 8277761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB].
    Yu T; Liu X; Yu Z; Yang S; Ye Y; Yang X; Gao Z
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):931-4. PubMed ID: 11832201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
    D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):39-43. PubMed ID: 7350387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of the myocardium during ischemic arrest. Dose-response curves for procaine and lignocaine in cardioplegic solutions.
    Hearse DJ; O'Brien K; Braimbridge MV
    J Thorac Cardiovasc Surg; 1981 Jun; 81(6):873-9. PubMed ID: 7230856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium concentration, lactobionate content, and sodium/ potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants.
    Termignon JL; Pradier F; Petit A; Journois D; Weiss M; Mazmanian M
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1126-35. PubMed ID: 8719460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion.
    Engelman DT; Watanabe M; Maulik N; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
    Circulation; 1996 Nov; 94(9 Suppl):II407-11. PubMed ID: 8901782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioplegia and slow calcium-channel blockers. Studies with verapamil.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):252-61. PubMed ID: 6876861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three methods of myocardial protection.
    Isselhard W; Schorn B; Hügel W; Uekermann U
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):329-36. PubMed ID: 6161431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.